Fully funded, mentored, one year research fellowship - part of a formal institutional Training Grant (NIH T32).
Depending on interest and skillset work can be in the areas of 1) Bariatric Embolization, 2) the development of new devices for use in IR, 3) the study of vascular anomalies.
Johns Hopkins Interventional Radiology has the most extensive Bariatric Embolization research program in the world, with over 15 years of experience and publication in this area. We have an active clinical research program in Bariatric Embolization with ongoing trials (BEATLES) and translational research (funded by NIDDK).
Johns Hopkins Interventional Radiology also has an established relationship with the Johns Hopkins Department of Biomedical Engineering, and is actively involved in the development of new interventional devices as well in the development of new applications of existing devices.
We also have the largest and most complete HHT and Vascular Anomalies Databases which serves as the basis for retrospective studies of these diseases in adults and children. Currently we are funded to examine the relationship between MR based radiomics and patient reported outcomes (PRO) measurements for low flow malformations, and to develop a new PRO for HHT.
Fellows are expected to submit abstracts and present data at national meetings as well as to publish manuscripts during their year.
Research fellows will be encouraged to attend morning conferences and to shadow IR faculty in clinical cases as time permits.
Applicants must be either a US citizen or green card holder, and have either an MD or DO (US diploma not required). Applicants must be accepted into an ACGME approved residency or fellowship (prefer but not limited to Radiology or DR/IR) but not yet on faculty. Can be from outside USA or Canada. Start date would be 7/1/23.
A background either in clinical research or in basic/translational research is preferred - but is optional. IR experience would also be preferred, but is optional.
Salary is set by NIH and accepted candidates will need to undergo NIH approval.
